Overall, these findings reveal the clinical significance of WDFY3‐AS2 and the essential roles of WDFY3‐AS2/miR‐2355‐5p/SOCS2 signalling axis in ESCC development and progression. Here, WDFY3 is linked to esophageal squamous cell carcinoma.